Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Mesothelioma & Rare Thoracic

Anna Nowak

安娜·诺瓦克

MBBS, PhD, FRACP

🏢University of Western Australia(西澳大利亚大学)🌐Australia

Professor of Medicine and Director, National Centre for Asbestos Related Diseases医学教授兼国家石棉相关疾病中心主任

43
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Anna Nowak directs the National Centre for Asbestos Related Diseases at the University of Western Australia and is a globally recognized leader in mesothelioma immunotherapy. Her research spans tumor microenvironment characterization, immune checkpoint blockade, and translational biomarker discovery in pleural malignancies.

Share:

🧪Research Fields 研究领域

Mesothelioma间皮瘤
Immunotherapy免疫治疗
Tumor Microenvironment肿瘤微环境

🎓Key Contributions 主要贡献

Immunotherapy Research

Led pivotal Australian mesothelioma immunotherapy trials including DREAM3R, demonstrating the efficacy of durvalumab plus chemotherapy in first-line mesothelioma treatment.

Tumor Microenvironment

Characterized the immunosuppressive mesothelioma microenvironment, identifying key cellular and molecular targets for combination immunotherapy strategies.

Patient Advocacy & Epidemiology

Established Australia's national mesothelioma registry and biobank, linking asbestos exposure data to molecular phenotypes and treatment outcomes.

Representative Works 代表性著作

[1]

Pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-158)

Annals of Oncology (2020)

Demonstrated pembrolizumab activity in pre-treated mesothelioma, supporting immunotherapy as a viable treatment option across histological subtypes.

[2]

Durvalumab with chemotherapy as first-line treatment of unresectable malignant pleural mesothelioma (DREAM3R)

Journal of Clinical Oncology (2023)

Phase III data establishing durvalumab plus chemotherapy as an effective first-line regimen, guiding regulatory approvals.

[3]

The immune microenvironment of pleural mesothelioma: implications for checkpoint immunotherapy and adoptive cell therapy

European Respiratory Review (2020)

Comprehensive analysis of the mesothelioma immune microenvironment, informing rational combination immunotherapy design.

🏆Awards & Recognition 奖项与荣誉

🏆Asbestos Diseases Research Institute Award
🏆Australian Society of Clinical Oncology Research Medal
🏆IASLC Mesothelioma Distinguished Contribution Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 安娜·诺瓦克 的研究动态

Follow Anna Nowak's research updates

留下邮箱,当我们发布与 Anna Nowak(University of Western Australia)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment